AccuraGen Overview

  • Founded
  • 2013
  • Status
  • Private
  • Employees
  • 24
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 10

AccuraGen General Information


Provider of a liquid biopsy technology designed to facilitate personalized cancer treatment. The company's technology circulates DNA from blood samples for cancer molecular diagnosis, enabling oncologists and clinicians to access sequencing-based cancer-mutation detection services.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Primary Office
  • 1505 O'Brien Drive
  • Suite B
  • Menlo Park, CA 94025
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AccuraGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Debt - PPP 15-Apr-2020 000.00 Completed Generating Revenue
4. Accelerator/Incubator 14-Sep-2016 000.00 Completed Generating Revenue
3. Early Stage VC (Series B) 01-Jun-2016 0000 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 06-Feb-2015 $6.9M $6.9M Completed Startup
1. Accelerator/Incubator Completed Startup
To view AccuraGen’s complete valuation and funding history, request access »

AccuraGen Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Provider of a liquid biopsy technology designed to facilitate personalized cancer treatment. The company's technology ci
Diagnostic Equipment
Menlo Park, CA
24 As of 2021
000000000 - 000.00


ation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderi
Hayward, CA
00 As of 0000
000000000 -

00000 00

por incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
San Diego, CA
00 As of 0000
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AccuraGen Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novodiax Private Debt Financed Hayward, CA 00 000000000 -
00000 0000000 0000 Venture Capital-Backed San Diego, CA 00 000.00 0000000000 0 000.00
000000000 Formerly VC-backed Milpitas, CA 00 000000&0
00000000 Private Equity-Backed Holliston, MA 00 000.00 000000000 - 000.00
000000000 00000000 Venture Capital-Backed Cambridge, United Kingdom 00 00000 0000000000 0 00000
You’re viewing 5 of 12 competitors. Get the full list »

AccuraGen Patents

AccuraGen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11120178-B2 Virtual reality system for designing brassiere Active 13-Jun-2019 000000000 0
US-20210244244-A1 Ergonomic toilet equipment Pending 18-Dec-2018 0000000000
US-20200187733-A1 Ergonomic toilet equipment Granted 18-Dec-2018 000000000
US-11033161-B2 Ergonomic toilet equipment Active 18-Dec-2018 000000000 0
US-20200139192-A1 Pelvic floor muscle training device and system Pending 03-Nov-2018 A63B23/20

AccuraGen Executive Team (7)

Name Title Board Seat Contact Info
Kang Ying Ph.D Co-Founder, Chairman & Chief Executive Officer
Zhaohui Sun Co-Founder & Chief Information Officer
Malek Faham Ph.D Interim Chief Scientific Officer
Paul Tang Ph.D Co-Founder
Li Weng Ph.D Vice President of Development
You’re viewing 5 of 7 executive team members. Get the full list »

AccuraGen Board Members (6)

Name Representing Role Since
Daniel Zabrowski Ph.D Decheng Capital Board Member 000 0000
Kang Ying Ph.D AccuraGen Co-Founder, Chairman & Chief Executive Officer 000 0000
Kelvin Liu Junson Capital Board Member 000 0000
Victor Tong Jr. Self Board Member 000 0000
Wei Xu Denlux Capital Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

AccuraGen Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AccuraGen Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
California Institute for Quantitative Biosciences Accelerator/Incubator 000 0000 000000 0
DT Capital Partners Venture Capital Minority 000 0000 000000 0
Junson Capital Family Office Minority 000 0000 000000 0
Pivotal Life Sciences Venture Capital Minority 000 0000 000000 0
StartX (US) Not-For-Profit Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »